Gluten Degradation, Pharmacokinetics, Safety, and Tolerability of TAK-062, an Engineered Enzyme to Treat Celiac Disease
Celiac disease (CeD) is an immune-mediated disorder triggered by the ingestion of gluten. TAK-062 is a novel, computationally designed endopeptidase under development for the treatment of patients with CeD.
